Terumo Corporation
BMV:4543 N Stok Raporu
Piyasa değeri: Mex$613.4b
Terumo Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6 Terumo şirketinin toplam hissedar öz sermayesi ¥1,313.5B ve toplam borcu ¥174.8B olup, bu da borç-öz sermaye oranını 13.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥1,752.3B ve ¥438.8B dir. Terumo 'in FAVÖK'ü ¥161.8B faiz karşılama oranı 88.8 dur. Şirketin ¥194.9B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler Faiz karşılama oranı 88.8x Nakit JP¥194.92b Eşitlik JP¥1.31t Toplam yükümlülükler JP¥438.75b Toplam varlıklar JP¥1.75t
Son finansal sağlık güncellemeleri
Tüm güncellemeleri göster
Second quarter 2025 earnings released: EPS: JP¥19.74 (vs JP¥18.49 in 2Q 2024) Nov 09
Less than half of directors are independent Oct 25
Terumo Corporation to Report Q2, 2025 Results on Nov 07, 2024 Sep 25 Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.01% for ¥30,000 million. Aug 30
Terumo Corporation to Report Q1, 2025 Results on Aug 08, 2024 Jun 02
Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview™? Monitoring System May 29
Full year 2024 earnings released: EPS: JP¥71.50 (vs JP¥59.50 in FY 2023) May 16
Less than half of directors are independent May 10
Less than half of directors are independent Apr 10
Terumo Corporation to Report Fiscal Year 2024 Results on May 14, 2024 Mar 17
Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 Feb 09 Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 Terumo Corporation, Annual General Meeting, Jun 26, 2024
Terumo Corporation to Report Q3, 2024 Results on Feb 07, 2024 Dec 03
Terumo Corporation to Report Q2, 2024 Results on Nov 14, 2023 Oct 01
Terumo Corporation (TSE:4543) announces an Equity Buyback for 5,000,000 shares, representing 0.67% for ¥20,000 million. Aug 10
Less than half of directors are independent Jul 11
Terumo Corporation to Report Q1, 2024 Results on Aug 09, 2023 Jun 21 Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 28, 2023; Provides Second Quarter-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 and Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024
Terumo Corporation, Annual General Meeting, Jun 27, 2023 May 16
Less than half of directors are independent Apr 19
Less than half of directors are independent Feb 22
Third quarter 2023 earnings released: EPS: JP¥39.97 (vs JP¥28.70 in 3Q 2022) Feb 11 Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023
Less than half of directors are independent Jan 30
Less than half of directors are independent Dec 27
Less than half of directors are independent Nov 16 Terumo Corporation Announces Dividend for the Second Quarter End of Fiscal Year 2023, Commences Dividend Payments on December 5, 2022; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023
Terumo Corporation to Report Q3, 2023 Results on Nov 10, 2023 Nov 10
Less than half of directors are independent Oct 21
Terumo Corporation to Report Q2, 2023 Results on Nov 10, 2022 Sep 28
Mitsui DM Sugar Holdings Co.,Ltd. (TSE:2109) agreed to acquire Enteral formula business of Terumo Corporation from Terumo Corporation (TSE:4543). Sep 09
NUTRI Co.,Ltd. entered into an agreement to acquire Nutritional food and related product assets of Terumo Corporation. Sep 08
First quarter 2023 earnings released: EPS: JP¥29.61 (vs JP¥36.90 in 1Q 2022) Aug 10 Terumo Corporation Provides Dividend Guidance for the Second Quarter of Year Ending March 31, 2023
Less than half of directors are independent Jul 18
Less than half of directors are independent Jul 05
Less than half of directors are independent May 30
Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan May 16 Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.98% for ¥50,000 million.
Less than half of directors are independent Apr 27
Terumo Corporation to Report Fiscal Year 2022 Results on May 12, 2022 Apr 08
Upcoming dividend of JP¥16.00 per share Mar 23
Investor sentiment deteriorated over the past week Mar 16
Less than half of directors are independent Mar 16
Terumo Corporation, Annual General Meeting, Jun 22, 2022 Feb 10 Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022
Investor sentiment deteriorated over the past week Jan 26
Less than half of directors are independent Jan 26
Second quarter 2022 earnings released: EPS JP¥29.22 (vs JP¥23.63 in 2Q 2021) Nov 08
Less than half of directors are independent Nov 08
Less than half of directors are independent Oct 20
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 4543 N 'nin kısa vadeli varlıkları ( ¥679.2B ) kısa vadeli yükümlülüklerini ( ¥231.0B ) aşıyor.
Uzun Vadeli Yükümlülükler: 4543 N şirketinin kısa vadeli varlıkları ( ¥679.2B ) uzun vadeli yükümlülüklerini ( ¥207.7B ) aşmaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 4543 N şirketinin toplam borcundan daha fazla nakiti var.
Borcun Azaltılması: 4543 N 'nin borç/öz sermaye oranı son 5 yılda 29.5% seviyesinden 13.3% seviyesine düştü.
Borç Kapsamı: 4543 N 'nin borcu işletme nakit akışı ( 110.8% ) tarafından iyi bir şekilde karşılanmaktadır.
Faiz Kapsamı: 4543 N 'in borcuna ilişkin faiz ödemeleri EBIT ( 88.8 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.
Sağlıklı şirketleri keşfedin Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}